Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study.

Ayşe Serra Artan,Şafak Mirioğlu,Zulal İstemihan,Elif Aksoy,Ahmet Burak Dirim,Bilger Çavuş,Özgür Akın Oto, Aslı Çifçibaşı-Örmeci,Fatih Beşışık,Yaşar Çalışkan,Savaş Öztürk,Halil Yazıcı,Sabahattin Kaymakoğlu,Aydın Türkmen

Balkan medical journal（2023）

引用 0|浏览8

暂无评分

摘要

Safety and efficacy of fixed-dose sofosbuvir/ledipasvir combination was effective and safe in kidney transplant recipients with hepatitis C virus. However, cautious monitoring of trough levels of calcineurin inhibitorss is needed due to potential drug-drug interactions during the treatment episode.

查看译文

关键词

sofosbuvir,ledipasvir,hepatitis,kidney transplant recipients,single-center

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要